The Straits Times reported that the Health Sciences Authority (HSA) has issued a warning to Riway Singapore, a Singapore-based company, to cease making false and misleading claims on the efficacy of its health supplement on cancer treatment.
An HSA spokesman said that an investigation is underway…
An HSA spokesman said that an investigation is underway and reminded that “sellers who falsely advertise health products are liable to prosecution and, if convicted, may be imprisoned for up to two years and/or fined up to $5,000.”
A recent presentation of Riway’s flagship product, Purtier Placenta, at the company’s Ang Mo Kio headquarters has been flagged to the HSA.
The Straits Times attended the presentation and observed that sellers made claims that Purtier Placenta can treat diseases. Customers also shared testimonies on how they saw improvements to their illness after consuming the supplement, which contains deer placenta.
“… Live stem cells would generally be destroyed by digestive enzymes in our stomach and gut when consumed orally.”
The HSA spokesman said: “There is no robust scientific evidence to support these claims. It is also not scientifically proven that oral stem cell therapy can prevent or treat diseases and medical conditions. Live stem cells would generally be destroyed by digestive enzymes in our stomach and gut when consumed orally.”
HSA also requested for a laboratory report dated 29th October 2008 to be removed from all marketing materials, citing the report’s use as “misleading”. The report was the result of a one-off test for the presence of heavy metals on a sample of a product and is not indicative of the product’s safety.
The HSA spokesman added that “anyone who misuses the laboratory report to falsely claim that HSA has endorsed the product is liable to be prosecuted for an offence of false advertising. If convicted, he may be imprisoned for up to two years and/or fined up to $5,000.”
The Straits Times attempts to reach out to Riway and founder Lim Boon Hong for comments were unsuccessful.
Seen anything interesting? Tip us off.